---
figid: PMC4051134__nihms363783f3
figtitle: Targeting JAK2 in the therapy of myeloproliferative neoplasms
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- NA
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Danio rerio
pmcid: PMC4051134
filename: nihms363783f3.jpg
figlink: /pmc/articles/PMC4051134/figure/F3/
number: F3
caption: Functional expression of JAK2 can be blocked at several levels. Deacetylase
  inhibitors (DACi) increase the acetylation and thus inhibit the chaperone function
  of HSP90 (heat shock protein 90). Inhibition of HSP90 leads to a reduction in levels
  of matured JAK2. Specific tyrosine kinase inhibitors prevent activation of downstream
  signaling cascades. Indicated are drugs that are currently in clinical trials for
  the treatment of MPNs. (see also http://cliniclatrials.gov)
papertitle: Targeting JAK2 in the therapy of myeloproliferative neoplasms.
reftext: Mamatha M. Reddy, et al. Expert Opin Ther Targets. ;16(3):313-324.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9573541
figid_alias: PMC4051134__F3
figtype: Figure
redirect_from: /figures/PMC4051134__F3
ndex: 13189bf2-dedd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4051134__nihms363783f3.html
  '@type': Dataset
  description: Functional expression of JAK2 can be blocked at several levels. Deacetylase
    inhibitors (DACi) increase the acetylation and thus inhibit the chaperone function
    of HSP90 (heat shock protein 90). Inhibition of HSP90 leads to a reduction in
    levels of matured JAK2. Specific tyrosine kinase inhibitors prevent activation
    of downstream signaling cascades. Indicated are drugs that are currently in clinical
    trials for the treatment of MPNs. (see also http://cliniclatrials.gov)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Jak2
  - Epo
  - Epx
  - Epor
  - Hsp90ab1
  - Hsp90aa1
  - Hsp84-2
  - Hsp84-3
  - Hsp86-ps2
  - Hsp86-ps1
  - Dach1
  - Fbxw4
  - ac
  - JAK2
  - EPO
  - TIMP1
  - EPX
  - EPOR
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - AADAC
  - FBXW4
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - kita
  - ngfra
  - jak2b
  - epoa
  - epor
  - hsp90aa1.1
  - fbxw4
  - Lestaurtinib
  - Ruxolitinib
  - AZD1480
  - SB1518
  - LY2784544
---
